Amlodipine and Retinal disorder - a phase IV clinical study of FDA data

Summary:

Retinal disorder is reported as a side effect among people who take Amlodipine (amlodipine besylate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Heparin, and have Sarcoma.

The phase IV clinical study analyzes which people have Retinal disorder when taking Amlodipine. It is created by eHealthMe based on reports of 346,875 people who have side effects when taking Amlodipine from the FDA, and is updated regularly.

What is Amlodipine?

Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 354,829 Amlodipine users. Check the latest studies of Amlodipine.

What is Retinal disorder?

Retinal disorder (disease of retina) is found to be associated with 325 drugs and 502 conditions by eHealthMe. Check the latest studies of Retinal disorder.

On Jul, 14, 2026

346,875 people reported to have side effects when taking Amlodipine.
Among them, 75 people (0.02%) have Retinal disorder.

Could Amlodipine cause Retinal disorder?

Among these 75 people:

How long have people been on Amlodipine when they have Retinal disorder? *

What is the gender of people who have Retinal disorder when taking Amlodipine? *

female: 67.69 %
male: 32.31 %

What is the age of people who have Retinal disorder when taking Amlodipine? *

What are other drugs people take besides Amlodipine? *

What are other side effects people have besides Retinal disorder? *

Cataract (clouding of the lens inside the eye): 16 people, 21.33%
Choroidal Effusion (fluid collection in vascular layer of eye that nourishes retina): 15 people, 20.00%
Vision Blurred: 13 people, 17.33%
Visual Acuity Reduced (reduced clearness of vision): 10 people, 13.33%
Weakness: 9 people, 12.00%
Eye Irritation: 9 people, 12.00%
Hypoaesthesia (reduced sense of touch or sensation): 8 people, 10.67%
Blood Pressure Fluctuation: 8 people, 10.67%
Tremor (trembling or shaking movements in one or more parts of your body): 8 people, 10.67%
Chest Pain: 8 people, 10.67%

What are the existing conditions these people have? *

Sarcoma (rare cancers that develop in the muscle, bone, nerves, cartilage, tendons, blood vessels and the fatty and fibrous tissues): 13 people, 17.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 10.67%
Diabetes: 6 people, 8.00%
Glaucoma (increased fluid pressure in the eye with vision loss): 6 people, 8.00%
High Blood Cholesterol: 5 people, 6.67%
Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 5 people, 6.67%
Multiple Myeloma (cancer of the plasma cells): 4 people, 5.33%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 2.67%
Hyperthyroidism (over activity of the thyroid gland): 2 people, 2.67%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 2 people, 2.67%

* Approximation only. Some reports may have incomplete information.

Do you take Amlodipine and have Retinal disorder?

- Check whether Retinal disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amlodipine:

Amlodipine (354,829 reports)

Browse all side effects of Amlodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Retinal disorder:

Retinal disorder (325 drugs)

Browse all the conditions that are associated with Retinal disorder:

Retinal disorder (502 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Amlodipine) and Amlodipine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.